Navigation Links
NIH scientists identify protective role for antibodies in Ebola vaccine study
Date:1/14/2013

WHAT:
Researchers at the National Institutes of Health (NIH) and Oregon Health & Science University (OHSU) have found that an experimental vaccine elicits antibodies that can protect nonhuman primates from Ebola virus infection. Ebola virus causes severe hemorrhagic fever in humans and nonhuman primates, meaning that infection may lead to shock, bleeding and multi-organ failure. According to the World Health Organization, Ebola hemorrhagic fever has a fatality rate of up to 90 percent. There is no licensed treatment or vaccine for Ebola virus infection.

Several research groups have developed experimental vaccine approaches that protect nonhuman primates from Ebola virus and the closely related Marburg virus. These approaches include vaccines based on DNA, recombinant adenovirus, virus-like particles, and human parainfluenza virus 3. But how these vaccine candidates confer protection is an area that is still being explored: Do they activate immune cells to kill the invading virus? Or do they elicit antibodies that block infection?

In this study, scientists at NIH's National Institute of Allergy and Infectious Diseases and OHSU's Vaccine & Gene Therapy Institute built on earlier work with an experimental vaccine composed of an attenuated vesicular stomatitis virus carrying a gene that codes for an Ebola virus protein. They observed how cynomolgus macaques responded to a challenge of Ebola virus before and during treatment with the vaccine and in conjunction with depleted levels of immune cells. Their results showed that important immune cellsCD4+ T cells and CD8+ T cellshad a minimal role in providing protection, while antibodies induced by the vaccine appeared to be critical to protecting the animals.

The scientists say this finding will help improve future Ebola virus vaccine development. They plan to focus their studies on what level of antibody production is needed to establish protection from Ebola virus infection in humans.

ARTICLE:
A Marzi et al. Antibodies are necessary for rVSV/ZEBOV-GP mediated protection against lethal Ebola virus challenge in nonhuman primates. Proceedings of the National Academy of Sciences. DOI: 10.1073/pnas.1209591110 (2013).

WHO:
Heinz Feldmann, M.D., Ph.D., chief of the Laboratory of Virology at NIAID's Rocky Mountain Laboratories. Dr. Feldmann is an expert on viral hemorrhagic fevers and emerging viruses.


'/>"/>

Contact: Ken Pekoc
kpekoc@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Related medicine news :

1. Scientists solving the mystery of human consciousness
2. Scientists uncover multiple faces of deadly breast cancer
3. Scientists identify major source of cells defense against oxidative stress
4. Scientists tailor cell surface targeting system to hit organelle ZIP codes
5. Scientists rewrite rulebook on breast cancer in landmark global study
6. Warwick scientists uncover how checkpoint proteins bind chromosomes
7. NIH scientists link quickly spreading gene to Asian MRSA epidemic
8. Joslin scientists identify important mechanism that affects the aging process
9. Scripps Research scientists show how memory B cells stay in class to fight different infections
10. Scientists Map Melanomas Genome
11. A*STAR scientists discover switch to boost anti-viral response to fight infectious diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2020)... ... 02, 2020 , ... Temprian, a spinoff from Northwestern University, ... lead indication is vitiligo. Vitiligo patients develop progressive depigmentation of the skin. There ... is equally prevalent in all ethnic groups, it is most visible and impactful ...
(Date:7/2/2020)... ... July 02, 2020 , ... Allegheny Health Network (AHN) today announced that ... Officer (CMIO), effective immediately. Dr. Lee succeeds Robert White, MD, who announced his ... end of the year to help support a seamless transition. , Dr. Lee joins ...
(Date:7/1/2020)... Calif. (PRWEB) , ... July 01, 2020 , ... ... of cannabis and botanically-derived terpenes, has officially released its new terpene infused ... brands a way for consumers to enjoy cannabis terpene profiles and flavors worldwide. ...
(Date:7/1/2020)... Texas (PRWEB) , ... July 01, 2020 , ... ... announced today that it has been selected by Codiak BioSciences to support its ... PODs will provide the cleanroom infrastructure for the drug substance and product manufacturing ...
(Date:6/28/2020)... , ... June 26, 2020 , ... PathAI, a global ... results of an exploratory analysis of digital scoring of PD-L1 expression to assess response ... poster #2017 at the 2020 American Association for Cancer Research (AACR) Annual Meeting. AACR ...
Breaking Medicine News(10 mins):
(Date:7/1/2020)... ... July 01, 2020 , ... The final ... Awards® is Tuesday, July 28. , The International Business Awards are ... the competition attracted more than 4,000 nominations from organizations in more than 70 ...
(Date:6/28/2020)... ... June 26, 2020 , ... Mediaplanet is proud ... together patients, healthcare providers, advocates, and scientists to spread awareness of chronic lung ... devastating respiratory conditions. , More than 35 million Americans live with ...
(Date:6/25/2020)... ... June 25, 2020 , ... BeCurious Studio LLC was ... DesignRush following the launch a recent project. BeCurious Studio, the rule breaking web/app ... , Commissioned by MyVictory Inc , the platform delivers a seamless, ...
Breaking Medicine Technology: